Beam Therapeutics to Present at Jefferies 2020 Virtual Healthcare Conference
Beam Therapeutics (Nasdaq: BEAM), a biotechnology company specializing in precision genetic medicine, announced that CEO John Evans will present at the Jefferies 2020 Virtual Healthcare Conference on June 4, 2020, at 9:30 a.m. ET. The conference runs from June 2-4, 2020. The presentation will be available via live webcast on the company's investor website, with an archive accessible for 60 days post-event. Beam Therapeutics focuses on base editing technology, creating precise genetic modifications without double-stranded DNA breaks, aiming to provide lasting solutions for serious diseases.
- None.
- None.
CAMBRIDGE, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will present at the Jefferies 2020 Virtual Healthcare Conference on Thursday, June 4, 2020 at 9:30 a.m. ET. The conference is being held virtually from June 2-4, 2020.
The live webcast will be available in the investor section of the company's website at www.beamtx.com. The webcast will be archived for 60 days following the presentation.
About Beam Therapeutics
Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company developing precision genetic medicines through the use of base editing. Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. For more information, visit www.beamtx.com.
Contacts:
Investors:
Alicia Davis, THRUST Strategic Communications
alicia@thrustsc.com
Media:
Dan Budwick
1AB
dan@1abmedia.com
FAQ
When will Beam Therapeutics present at the Jefferies 2020 Virtual Healthcare Conference?
How can I watch the Beam Therapeutics presentation?
What is the focus of Beam Therapeutics' research?
How long will the Beam Therapeutics presentation be available after it airs?
What technology does Beam Therapeutics use for genetic editing?
